Bioimpacts of dialyzer variety on phosphorus level in Iranian hemodialysis patients

Area of Science:

• Nephrology
• Cardiovascular Medicine

Background:

• Cardiovascular events are a leading cause of mortality in chronic renal failure patients.
• Hyperphosphatemia, common in dialysis patients due to reduced phosphorus clearance, contributes to cardiovascular complications.
• Secondary hyperparathyroidism, linked to hyperphosphatemia, also impacts cardiovascular health.

Purpose of the Study:

• To evaluate the effect of different dialyzer types on serum phosphorus levels in hemodialysis patients.
• To assess phosphorus levels as a prognostic factor after dialysis using various dialyzers.

Main Methods:

• Six dialyzer types were used: low flux (F7, F8), high flux (F70, F80), and hollow-fiber (PES 130 HF, PS 13 LF).
• Fifty-seven patients were divided into six matched groups (9-10 patients per group) and treated for one month.
• Serum phosphorus levels were measured before and after the one-month dialysis period.

Main Results:

• No statistically significant differences were observed in pre-dialysis or post-dialysis serum phosphorus levels between the groups after one month.
• Mean pre-dialysis phosphorus ranged from 4.6 to 5.4 mg/dl, and mean post-dialysis phosphorus ranged from 4.17 to 5.43 mg/dl across groups.
• Individual pre- and post-dialysis phosphorus levels within each group showed no significant change over the study duration.

Conclusions:

• Dialyzer type demonstrated no short-term effectiveness in controlling serum phosphorus levels during hemodialysis.
• Longer-term studies are suggested to fully understand the impact of dialyzer choice on phosphorus management.